The U.S. Preventive Services and Task Force (USSTF) recommends screening for<unk>  in sexually active women age 24 years and younger and in older women who are at increased risk for infection. Currently available evidence is insufficient to assess the balance of benefits and harms of screening for<unk>  in heterosexual men. USSTF recommends at least annual screenings for<unk>  among men who have sex with men (MSM).
Gonorrhea screening
Cervicitis screening
Trichomoniasis screening
Bacterial vaginosis screening
Chlamydia infection screening
Iron deficiency anemia screening
Gastritis screening
Malaria screening